{"organizations": [], "uuid": "733460325a4cf12c90cd2fbeb1bd85b080a5b36c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-morphotek-announces-fda-acceptance/brief-morphotek-announces-fda-acceptance-of-ind-for-cancer-treatment-idUSASB0C0JO", "country": "US", "domain_rank": 408, "title": "BRIEF-Morphotek Announces FDA Acceptance Of IND For Cancer Treatment", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-10T16:35:00.000+02:00", "replies_count": 0, "uuid": "733460325a4cf12c90cd2fbeb1bd85b080a5b36c"}, "author": "", "url": "https://www.reuters.com/article/brief-morphotek-announces-fda-acceptance/brief-morphotek-announces-fda-acceptance-of-ind-for-cancer-treatment-idUSASB0C0JO", "ord_in_thread": 0, "title": "BRIEF-Morphotek Announces FDA Acceptance Of IND For Cancer Treatment", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "eisai co ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 10, 2018 / 2:35 PM / Updated 28 minutes ago BRIEF-Morphotek Announces FDA Acceptance Of IND For Cancer Treatment Reuters Staff \nJan 10 (Reuters) - Eisai Co Ltd: \n* MORPHOTEK ANNOUNCES FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR NEXT-GENERATION FARLETUZUMAB ANTIBODY-DRUG CONJUGATE MORAB-202 \n* MORPHOTEK - U.S. FDA ACCEPTED INVESTIGATIONAL NEW DRUG APPLICATION FOR MORAB-202 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-10T16:35:00.000+02:00", "crawled": "2018-01-10T16:56:02.030+02:00", "highlightTitle": ""}